DB
CATX icon

Dmitry Balyasny’s Perspective Therapeutics CATX Stock Holding History

Dmitry Balyasny’s Portfolio CATX Stock Details CATX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.3M Buy
3,320,224
+325,764
+11% +$1.23M 0.01% 1000
2026
Q1 		$12.5M Buy
+2,994,460
New +$12.7M 0.02% 932
2025
Q1 		– Sell
-130,914
Closed -$418K – 2831
2024
Q4 		$418K Buy
+130,914
New +$1.07M ﹤0.01% 2257
2024
Q2 		– Sell
-11,172
Closed -$133K – 2616
2024
Q1 		$133K Buy
+11,172
New +$95.3K ﹤0.01% 2474

Other funds holding CATX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 247.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Dmitry Balyasny's CATX Position: Q2 2026 in Review

Dmitry Balyasny increased its Perspective Therapeutics (CATX) stake by 11% in Q2 2026, buying an estimated $1.23M and bringing the position to 3,320,224 shares worth $11.3M. The position accounts for 0.01% of the portfolio, ranked #1000.

Dmitry Balyasny first reported a position in CATX in Q1 2024 and has held it in 4 quarters since. The position peaked at $12.5M in Q1 2026. 131 funds tracked by Wall St. Rank hold CATX as of Q2 2026.

  • Dmitry Balyasny held 3,320,224 shares of Perspective Therapeutics worth $11.3M as of Q2 2026.
  • Dmitry Balyasny bought 325,764 Perspective Therapeutics shares in Q2 2026, an estimated $1.23M.
  • Perspective Therapeutics made up 0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #1000 holding.
  • Dmitry Balyasny first reported a position in Perspective Therapeutics in Q1 2024 and has held it in 4 quarters since.
  • Dmitry Balyasny's Perspective Therapeutics position peaked at $12.5M in Q1 2026.
  • 131 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.